Daily non-political popular news in brief.

OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival

06-01-2007 · EurekAlert!

Oregon Health & Science University Cancer Institute researchers have identified a protein that is a strong indicator of survival for men with advanced prostate cancer. The C-reactive protein, also known as CRP, is a special type of protein produced by the liver that is elevated in the presence of inflammation.

Keywords: ohsu, cancer, institute, researcher, identifies, protein, marker, prostate, survival, identify

« Previous | Next »

Similar news on "OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival":

OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
06-02-2007 · EurekAlert!
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
Similar news · Read more »
OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence
02-14-2008 · EurekAlert!
An Oregon Health & Science University Cancer Institute researcher has found a biomarker that may help improve the ability to predict if a man's prostate cancer is going to come back after surgical removal.
Similar news · Read more »
High PSA velocity linked with low survival rates
10-31-2006 · EurekAlert!
The rate at which prostate-specific antigen levels change may help identify men with life-threatening prostate cancer, according to a study in the November 1 issue of the Journal of the National Cancer Institute.
Similar news · Read more »
OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia
12-10-2007 · EurekAlert!
Oregon Health & Science University Cancer Institute researcher Jeff Tyner, Ph.D., has created a way to identify proteins that are candidates for targeted therapy in acute myeloid leukemia using an assay that yields results in just four days.
Similar news · Read more »
VA researcher finds way to identify which men need a second biopsy
02-22-2007 · EurekAlert!
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
Similar news · Read more »
Emory researchers identify signaling protein for multiple myeloma
09-10-2007 · EurekAlert!
Researchers at Emory University's Winship Cancer Institute are the first to discover a mechanism that plays a critical role in the multiple myeloma cell cycle and survival. Their research may result in identification of a new therapeutic target for treating multiple myeloma.
Similar news · Read more »
OHSU Cancer Institute researcher discovers what fuels certain cancer mutation
12-10-2007 · EurekAlert!
An Oregon Health & Science University Cancer Institute researcher has discovered that a particular hormone is responsible for driving a cancer enzyme to cause an often deadly red blood cell cancer. Researchers working with the cancer mutation in the JAK2 enzyme have found that the enzyme is dependent on the hormone TNF-alpha to grow and cause a red blood cell cancer called polycythemia vera, said principal investigator Thomas Bumm, M.D., Ph.D., OHSU Cancer Institute member.
Similar news · Read more »
'Network' approach identifies potential breast cancer susceptibility gene
10-09-2007 · EurekAlert!
Like a crossword-puzzle solver who uses the letters in some answers to figure out others, researchers at Dana-Farber Cancer Institute and an international group of collaborators have used data on genes involved in inherited forms of breast cancer to identify a gene linked to non-hereditary cases of the disease.
Similar news · Read more »
Algae Provide New Clues To Cancer
10-13-2006 · ScienceDaily
A microscopic green alga helped scientists at the Salk Institute for Biological Studies identify a novel function for the retinoblastoma protein (RB), which is known for its role as a tumor suppressor in mammalian cells. By coupling cell size with cell division, RB ensures that cells stay within an optimal size range.
Similar news · Read more »
Other highlights in the May 16 JNCI
05-15-2007 · EurekAlert!
Also in the May 16 JNCI is a study linking moderate drinking and renal cell cancer, second cancers in childhood leukemia and lymphoma survivors, a study that finds no connection between clodronate and prostate cancer survival, and a protein that may prevent cancer cells from dying.
Similar news · Read more »